Appia Provides Update on its Extensive Drilling Program at its PCH Ionic Clay Project, Brazil
Toronto, Ontario–(ACN Newswire – September 28, 2023) – Appia Rare Earths & Uranium Corp. (CSE: API)…
Month: September 2023
Enterprise Viewpoint Ranks Gradient AI as Top 20 Innovative InsurTech Solution Provider
Recognized for its Innovative AI Solutions for Insurance Underwriting and Claims Management BOSTON–(BUSINESS WIRE)–#AIinInsurance—Gradient AI,…
Sarcos Awarded $13.8 Million USD Contract by U.S. Air Force for Advancement of Its Artificial Intelligence and Machine Learning Software
Contract will support continued development of Sarcos artificial intelligence and machine learning framework to advance…
BlackRock Expands Active ETF Suite With Equity Premium Income Strategy
Providing investors a differentiated income strategy which couples high income potential with long term growth…
DwellWell Introduces AI in Real Estate Scholarship
Students enter by submitting a video about the future of AI in real estate LOS…
Epic Bio to Present Preclinical Data at 28th International Annual Congress of the World Muscle Society
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
Epic Bio to Present Preclinical Data at 28th International Annual Congress of the World Muscle Society
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
Lexicon to Present Post Hoc Analysis of Scored Clinical Trial at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023
INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failure SCORED was one of…
Lexicon to Present Post Hoc Analysis of Scored Clinical Trial at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023
INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failure SCORED was one of…
Nusano to Participate in October Investor Conferences
NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) — Nusano, Inc., a company reshaping the production…
Nusano to Participate in October Investor Conferences
NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) — Nusano, Inc., a company reshaping the production…
Green Water Labs Introduces Algae Assassin, The Environmentally Conscious Solution for Home Outdoor Algae Removal
Revolutionary Cleaner Utilizes Organic Waste to Safely and Effectively Remove Algae from Outdoor Surfaces Green…
Green Water Labs Introduces Algae Assassin, The Environmentally Conscious Solution for Home Outdoor Algae Removal
Revolutionary Cleaner Utilizes Organic Waste to Safely and Effectively Remove Algae from Outdoor Surfaces Green…
Viralgen Vector Core and Elpida Therapeutics partner to manufacture gene therapy medicines for anticipated Spastic Paraplegia 50 (SPG50) and Charcot-Marie-Tooth disease type 4J (CMT4J) clinical trials
Trial participants with Spastic Paraplegia 50 (SPG50) and Charcot-Marie-Tooth disease type 4J (CMT4J) could benefit…
Viralgen Vector Core and Elpida Therapeutics partner to manufacture gene therapy medicines for anticipated Spastic Paraplegia 50 (SPG50) and Charcot-Marie-Tooth disease type 4J (CMT4J) clinical trials
Trial participants with Spastic Paraplegia 50 (SPG50) and Charcot-Marie-Tooth disease type 4J (CMT4J) could benefit…
Biomea Fusion Announces FDA and Health Canada Clearance of the Expansion Cohorts of the Ongoing COVALENT-111 Phase II Study
The FDA and Health Canada have cleared the initiation of the expansion portion of COVALENT-111,…
Biomea Fusion Announces FDA and Health Canada Clearance of the Expansion Cohorts of the Ongoing COVALENT-111 Phase II Study
The FDA and Health Canada have cleared the initiation of the expansion portion of COVALENT-111,…
IMUNON Reports Interim Progression-Free Survival and Overall Survival Data in Phase 1/2 OVATION 2 Study in Advanced Ovarian Cancer
Intent-to-treat population shows 9-month OS improvement over control arm Subgroup of patients treated with IMNN-001…
IMUNON Reports Interim Progression-Free Survival and Overall Survival Data in Phase 1/2 OVATION 2 Study in Advanced Ovarian Cancer
Intent-to-treat population shows 9-month OS improvement over control arm Subgroup of patients treated with IMNN-001…
Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid
Data published in the Journal of Burn Care & Research show treatment with NexoBrid resulted…